Table 4 Principal cause of reduced best‐corrected vision in operated eyes.
| Cause | Best corrected visual acuity, n (%) | |||
|---|---|---|---|---|
| <6/12 to 6/18 | <6/18 to 6/60 | <6/60 to 3/60 | <3/60 | |
| Posterior capsule/hyaloid face opacification* | 43 (66.2) | 111 (49.8) | 24 (47.1) | 65 (22.3) |
| Other operative complications† | 2 (3.1) | 22 (9.9) | 2 (3.9) | 41 (14) |
| Central corneal opacity | 3 (4.6) | 29 (13.0) | 6 (11.8) | 70 (24) |
| Glaucoma | 3 (4.6) | 8 (3.6) | 4 (7.8) | 49 (16.8) |
| Age‐related macular degeneration | 6 (9.2) | 9 (4.0) | 7 (13.7) | 25 (8.6) |
| Diabetic retinopathy | 3 (4.6) | 7 (3.1) | 2 (3.9) | 7 (2.4) |
| Amblyopia | 8 (3.6) | 7 (2.4) | ||
| Optic atrophy | 5 (2.2) | 1 (2) | 8 (2.7) | |
| Retinitis pigmentosa | 1 (1.5) | 3 (1.3) | 1 (0.3) | |
| Other anterior segment pathology | 2 (0.9) | 2 (0.7) | ||
| Other maculopathy‡ | 2 (3.1) | 3 (1.3) | 1 (2) | 4 (1.4) |
| Vitreous haemorrhage | 1 (2) | 2 (0.7) | ||
| Pathology suspected but unconfirmed | 2 (3.1) | 16 (7.2) | 3 (5.9) | 11 (3.8) |
| All | 65 (100) | 223 (100) | 51 (100) | 292 (100) |
*119 were ECCE+IOL (32 saw <6/12 to 6/18, 62 saw <6/18 to 6/60, 9 saw <6/60 to 3/60, 16 saw <3/60); 122 were ICCE (10 saw <6/12 to 6/18, 49 saw <6/18 to 6/60, 15 saw <6/60 to 3/60, 48 saw <3/60); 2 were couched (1 saw <6/12 to 6/18, 1 saw <3/60).
†Excluding posterior capsule opacification.
‡For example, myopic maculopathy, macular dystrophy, macular hole.